SUBSCRIBE
Search JIM Advanced Search

Journal of Chinese Integrative Medicine ›› 2006, Vol. 4 ›› Issue (2): 166-174.doi: 10.3736/jcim20060212

• Original Experimental Research • Previous Articles     Next Articles

Effects of Chinese herbal medicine on modulating the course of puberty development in children with precocious puberty

De-pei Cai1, Bo-ying Chen2, Wei Zhang3, Pin Li1   

  1. 1. Department of Integrated Chinese and Western Medicine, Pediatric Hospital, Fudan University, Shanghai 200032, China
    2. Department of Neurobiology, Medical College, Fudan University, Shanghai 200032, China
    3. Department of Molecular Biology, Shanghai PASIC Bioengineer Institute, Shanghai 200032, China
  • Online:2006-03-20 Published:2006-03-15

RichHTML

0

PDF (PC)

57

Like

Objective

To explore the therapeutic effects of Ziyin Xiehuo Recipe (ZYXHR) for nourishing yin and lowering fire and Yishen Tianjing Recipe (YSTJR) for nourishing kidney and replenishing essence on regulating the gonadotrophic and somatotrophic functions of hypothalamic-pituitary axis, and to reveal the mechanisms of ZYXHR and YSTJR in modulating the course of pubertal development of children with precocious puberty.

Methods

The pubertal rats were fed with ZYXHR or YSTJR for 30 days, and the parameters of rats were monitored as the followings: The content of gonadotropin-releasing hormone（GnRH）, the frequency and amplitude of GnRH impulse releasing, the releasing amounts of aminoacid neurotransmitters, and neuropeptide Y (NPY) and β-endorphin (β-END) in the gonadotrophic area of the hypothalamus were detected with neurobiological methods (push-pull perfusion, homogenate, incubation of brain slices, and immunohistochemical staining). The levels of gene and protein expressions of GnRH, growth hormone releasing hormone (GHRH) and somatostatin (SS) in hypothalamus, and follicular stimulating hormone (FSH), luteinizing hormone (LH) and growth hormone (GH) in adenohypophysis as well as insulin-like growth factorⅠ (IGF-Ⅰ) in metaphysis were determined with real time reverse transcription-polymerase chain reaction (RT-PCR).

Results

The ZYXHR could reduce the activity of GnRH neurons in hypothalamus through inhibiting the release of central exciting aminoacid neurotransmitters, whereas promoting the release of central inhibiting aminoacid neurotransmitters, NPY and β-END in gonadotrophic area of hypothalamus. The expression levels of GnRH, FSH and LH mRNAs were down-regulated while the expression level of SS mRNA in hypothalamus was up-regulated in the ZYXHR-treated group. The GH mRNA in hypophysis and the IGF-Ⅰ mRNA in metaphysis were both down-regulated by ZYXHR. The YSTJR could promote the activity of GnRH neurons in hypothalamus through inhibiting the release of NPY in gonadotrophic area of hypothalamus, up-regulating the expression levels of GnRH, FSH, LH and GH mRNAs in hypophysis, and IGF-Ⅰ mRNA in metaphysis, while down-regulating the expression level of SS mRNA in hypothalamus.

Conclusion

The ZYXHR and YSTJR could both regulate the gonadotrophic and somatotrophic functions of hypothalamic-pituitary axis through modulating the neuroendocrine regulation and the gene expressions of GnRH and SS in hypothalamus, GH, FSH and LH in hypophysis, and IGF-Ⅰ in metaphysis. These may be the chief mechanisms of ZYXHR and YSTJR in modulating the course of pubertal development and ameliorating the skeletal development in children with precocious puberty.

Key words: Chinese materia medica, Puberty, Precocious, Neurotransmitters, Neuropeptide Y, β-endorphin, Hypothalamic-pituitary-gonadal axis,

CLC Number: 

  • R585

Table 1

Effects of ZYXHR on releasing contents of aminoacid transmitters and β-END in preoptic area of hypothalamus (ヌ±S, nmol/L)"

Group n Asp Glu GABA β-END
Normal control 6 120.29±117.01 161.53±101.75 104.74±71.81 372.57±156.24
ZYXHR-treated 6 33.10±13.34* 76.15±46.10* 238.79±104.13** 619.51±195.20*

Table 2

Effects of ZYXHR and YSTJR on NPY contents in hypothalamus (ヌ±S)"

Group n NPY (integrated optic density)
MPOA ARC ME
Normal control 5 0.26±0.09 0.57±0.31 0.63±0.10
ZYXHR-treated 5 0.45±0.16* 0.93±0.46* 0.97±0.51*
YSTJR-treated 5 0.34±0.05 0.32±0.08* 0.43±0.22*

Table 3

Effects of ZYXHR on impulse releasing of GnRH in preoptic area of hypothalamus (ヌ±S)"

Group n Pulse interval（min) Pulse amplitude(ng/L)
Normal control 5 104.00±22.80 40.36±10.05
ZYXHR-treated 5 ≥180** 28.31±5.88*

Table 4

Effects of ZYXHR and YSTJR on GnRH contents in homogenate of preoptic area of hypothalamus (ヌ±S, pg/mg)"

Group n GnRH
Normal control 5 42.77±13.39
ZYXHR-treated 8 30.77±8.57
YSTJR-treated 7 152.28±113.07*

Table 5

Effects of ZYXHR on GnRH releasing in medial basal hypothalamus (ヌ±S,ng/L)"

Group n GnRH contents in incubating solution
Basic level Activated release
Normal control 10 34.82±18.09 83.44±14.38
ZYXHR-treated 10 36.10±21.23 65.21±30.40*

Table 6

Effects of ZYXHR and YSTJR on GnRH contents in hypothalamus (ヌ±S)"

Group n GnRH (integrated optic density)
MPOA ARC ME
Normal control 5 0.97±0.60 0.84±0.08 0.86±0.14
ZYXHR-treated 5 0.19±0.04** 0.41±0.13** 0.49±0.11**
YSTJR-treated 5 1.96±0.64* 1.98±0.36** 3.14±0.27**

Figure 1

Effects of ZYXHR and YSTJR on GnRH contents in hypothalamusA: Positive expression of GnRH in MPOA in normal control group (×100); B: Positive expression of GnRH in ARC in normal control group (×200); C: Positive expression of GnRH in ME in normal control group (×200); D: Positive expression of GnRH in MPOA in ZYXHR-treated group (×100); E: Positive expression of GnRH in ARC in ZYXHR-treated group (×200); F: Positive expression of GnRH in ME in ZYXHR-treated group (×200); G: Positive expression of GnRH in MPOA in YSTJR-treated group (×100); H: Positive expression of GnRH in ARC in YSTJR-treated group (×200); I: Positive expression of GnRH in ME in YSTJR-treated group (×200)."

Table 7

Effects of ZYXHR and YSTJR on expressions of GnRH gene in hypothalamus, and FSH and LH genes in hypophysis (ヌ±S)"

Group n Integrated optic density
GnRH cDNA FSH cDNA LH cDNA
Normal control 10 0.045±0.008 0.566±0.008 0.406±0.019
ZYXHR-treated 10 0.416±0.013** 0.518±0.012** 0.375±0.009**
YSTJR-treated 10 0.534±0.011** 0.629±0.011** 0.434±0.022**

Table 8

Effects of ZYXHR and YSTJR on expression level of SS mRNA in periventricular nucleus of hypothalamus (ヌ±S)"

Group n SS mRNA
Amount of positive Amount of positive neurons Areal optic density of
neurons per unit area （/mm2） positive neurons
Normal control 6 124.28±14.19 55.23±5.75 4 688.72±786.60
ZYXHR-treated 6 165.22±36.44* 73.43±15.64* 6 813.60±889.18*
YSTJR-treated 6 91.61±10.91* 40.72±7.41* 2 912.33±132.47*

Table 9

Effects of ZYXHR and YSTJR on expression level of SS protein in periventricular nucleus of hypothalamus (ヌ±S)"

Group n SS protein
Amount of positive Amount of positive neurons Areal density of
neurons per unit area （/mm2） positive neurons
Normal control 6 98.11±15.50 43.60±6.34 4 651.72±607.33
ZYXHR-treated 6 143.83±23.24* 62.82±10.13* 8 321.22±1041.40*
YSTJR-treated 6 61.39±9.51* 25.80±4.27* 3 424.94±884.56*

Figure 2

Positive neurons of SS mRNA in periventricular nucleus of hypothalamus in three groupsA: Normal control group; B： ZYXHR-treated group; C: YSTJR-treated group."

Figure 3

Positive neurons of SS protein in periventricular nucleus of hypothalamus in three groupsA: Normal control group; B： ZYXHR-treated group; C: YSTJR-treated group."

Table 10

Effects of ZYXHR and YSTJR on expression level of GHRH mRNA in ARC of hypothalamus (ヌ±S)"

Group n GHRH mRNA
Amount of positive neurons Areal optic density of positive neurons
Normal control 6 27.17±4.4 0.125±0.026
ZYXHR-treated 6 27.44±5.0 0.120±0.027
YSTJR-treated 6 28.06±3.5 0.127±0.028

Figure 4

Positive neurons of GHRH mRNA in ARC of hypothalamus in three groupsA: Normal control group： B; ZYXHR-treated group; C: YSTJR-treated group."

Table 11

Effects of ZYXHR and YSTJR on gene copy number of GH cDNA in hypophysis and IGF-Ⅰ cDNA in liver and metaphysis (ヌ±S, ×107 copy)"

Group n GH IGF-Ⅰ in liver IGF-Ⅰ in metaphysis
Normal control 10 19.38±6.69 16.80±6.57 2 141.0±585.38
ZYXHR-treated 10 7.08±1.20* 6.39±1.61* 228.5±65.73*
YSTJR-treated 10 44.69±9.14* 40.50±16.27* 3 860.43±673.00*

Table 12

Effects of ZYXHR and YSTJR on GH cells in adenohypophysis (ヌ±S)"

Group n Single cell area (μm2) Amount of positive cell (/field of vision) Positive cell area (μm2)
Normal control 10 47.66±5.53 557.08±62.74 25 776.85±2110.37
ZYXHR-treated 10 34.21±3.06* 455.09±35.96* 20 806.55±1784.75*
YSTJR-treated 10 43.43±4.29 704.80±55.66* 298 99.60±4014.45*

Figure 5

GH-positive cells in adenohypophysis in three groupsA: Normal control group; B：ZYXHR-treated group; C: YSTJR-treated group."

[1] Cai DP, Ji ZY, Chen BY , et al. Pathogenetic regularity of female precocious puberty and the mechanism of therapy with TCM[J]. Chin J Integr Med, 2001,7(2):132-134
doi: 10.1007/BF02935023
[2] 李嫔, 向正华, 蔡德培 . 中药对大鼠下丘脑生长抑素及垂体生长激素基因表达与蛋白表达的调节作用[J]. 中国中西医结合杂志, 2003,23(3):207-210
doi: 10.7661/CJIM.2003.3.207
[3] 沈皓, 蔡德培, 陈伯英 . 补肾中药对下丘脑-垂体促性腺机能的影响[J]. 中西医结合学报, 2004,2(1):53-57
[4] Wetsel WC, Valenca MM, Mercanthaler I , et al. Intrinsic pulsatile secretory activity of immortalized luteinizing hormone-releasing hormone-secreting neurons[J]. Proc Nact Acad Sci U S A, 1992,89(9):4149-4153
[5] Wu FC, Butler GE, Kelnar CJ , et al. Ontogeny of pulsatile gonadotropin releasing hormone secretion from midchildhood, through puberty, to adulthood in the human male: a study using deconvolution analysis and an ultrasensitive immunofluorometric assay[J]. J Clin Endocrinol Metab, 1996,81(5):1798-1805
[6] Bourguignon JP, Franchimont P . Puberty-related increase in episodic LHRH release from rat hypothalamus in vitro[J]. Endocrinology, 1984,114(5):1941-1943
doi: 10.1210/endo-114-5-1941 pmid: 6370671
[7] Spergel DJ, Krsmanoric LZ, Stojilkovic SS , et al. Glutamate modulates [Ca2+]i and gonadotropin-releasing hormone secretion in immortalized hypothalamic GT1-7 neurons[J]. Neuroendocrinology, 1994,59(4):309-317
[8] Jarry H, Hirsch B, Leonhardt S , et al. Amino acid neurotransmitter release in the preoptic area of rats during the positive feedback actions of estradiol on LH release[J]. Neuroendocrinology, 1992,56(2):133-140
[9] Kawano H, Daikoku S . Somatostatin-containing neuron systems in the rat hypothalamus: retrograde tracing and immunohistochemical studies[J]. J Comp Neurol, 1988,271(2):293-299
[10] McCarthy GF, Beaudet A, Tannenbaum GS . Colocalization of somatostatin receptors and growth hormone-releasing factor immunoreactivity in neurons of the rat arcuate nucleus[J]. Neuroendocrinology, 1992,56(1):18-24
[1] Chang-quan Ling. Traditional Chinese medicine is a resource for drug discovery against 2019 novel coronavirus (SARS-CoV-2). Journal of Integrative Medicine, 2020, 18(2): 87-88.
[2] Syed Fairus, Hwee Ming Cheng, Kalyana Sundram. Antioxidant status following postprandial challenge of two different doses of tocopherols and tocotrienols. Journal of Integrative Medicine, 2020, 18(1): 68-79.
[3] Mohadeseh Ostovar, Abolfazl Akbari, Mohammad Hossein Anbardar, Aida Iraji, Mohsen Salmanpour, Salar Hafez Ghoran, Mojtaba Heydari, Mesbah Shams. Effects of Citrullus colocynthis L. in a rat model of diabetic neuropathy. Journal of Integrative Medicine, 2020, 18(1): 59-67.
[4] Nadiah Razali, Aidiahmad Dewa, Mohd Zaini Asmawi, Nornisah Mohamed, Nurul Maizan Manshor. Mechanisms underlying the vascular relaxation activities of Zingiber officinale var. rubrum in thoracic aorta of spontaneously hypertensive rats. Journal of Integrative Medicine, 2020, 18(1): 46-58.
[5] Gerli E.G. Herr, Fábio Goulart da Silva, Francisco José Cidral-Filho, Fabricia Petronilho, Lucinéia Gainski Danielski, Mariana Pereira de Souza Goldim, Afonso Shiguemi Inoue Salgado, Franciane Bobinski, Daniel Fernandes Martins, Eliane R. Winkelmann. Effects of the use of bioceramic wraps in patients with lower limb venous ulcers: A randomized double-blind placebo-controlled trial. Journal of Integrative Medicine, 2020, 18(1): 27-.
[6] Álisson de Carvalho Gonçalves, Einy Jéssika Siqueira Moreira, Guilherme Vannucchi Portari. Benfotiamine supplementation prevents oxidative stress in anterior tibialis muscle and heart. Journal of Integrative Medicine, 2019, 17(6): 423-429.
[7] Yi Ran Hu, San Li Xing, Chuan Chen, Ding Zhu Shen, Jiu Lin Chen. Tiaoxin Recipe, a Chinese herbal formula, inhibits microRNA-34a expression in the APPswe/PS1ΔE9 mouse model of Alzheimer's disease. Journal of Integrative Medicine, 2019, 17(6): 404-409.
[8] Rebecca Kulbida, Alexander Mathes, Johannes Loeser. Beneficial effects of hirudotherapy in a chronic case of complex regional pain syndrome. Journal of Integrative Medicine, 2019, 17(5): 383-386.
[9] Sandip B. Bharate, Vikas Kumar, Sonali S. Bharate, Bikarma Singh, Gurdarshan Singh, Amarinder Singh, Mehak Gupta, DeepikaSingh, AjayKumar, Surjeet Singh, Ram A. Vishwakarma. Discovery and preclinical development of IIIM-160, a Bergenia ciliata-based anti-inflammatory and anti-arthritic botanical drug candidate. Journal of Integrative Medicine, 2019, 17(3): 192-204.
[10] Asmae Assaidi, Ikram Dib, Monique Tits, Luc Angenot, Said Bellahcen, Nourelhouda Bouanani, Abdelkhaleq Legssyer, Mohammed Aziz, Hassane Mekhfi, Mohammed Bnouham, Michel Frederich, Abderrahim Ziyyat. Chenopodium ambrosioides induces an endothelium-dependent relaxation of rat isolated aorta. Journal of Integrative Medicine, 2019, 17(2): 115-124.
[11] Mary Abiola Okesola, Basiru Olaitan Ajiboye, Babatunji Emmanuel Oyinloye, Oluwafemi Adeleke Ojo. Neuromodulatory effects of ethyl acetate fraction of Zingiber officinale Roscoe extract in rats with lead-induced oxidative stress. Journal of Integrative Medicine, 2019, 17(2): 125-131.
[12] Carlos R. Oliveira, Daniel G. Spindola, Daniel M. Garcia, Adolfo Erustes, Alexandre Bechara, Caroline Palmeira-dos-Santos, Soraya S. Smaili, Gustavo J.S. Pereira, André Hinsberger, Ezequiel P. Viriato, Maria Cristina Marcucci, Alexandra C.H.F. Sawaya, Samantha L. Tomaz, Elaine G. Rodrigues, Claudia Bincoletto. Medicinal properties of Angelica archangelica root extract: Cytotoxicity in breast cancer cells and its protective effects against in vivo tumor development. Journal of Integrative Medicine, 2019, 17(2): 132-140.
[13] Yoshimi Yamakami, Kyoko Morino, Yuki Takauji, Ryuichiro Kasukabe, Kensuke Miki, Mohammad Nazir Hossain, Dai Ayusawa, Michihiko Fujii. Extract of Emblica officinalis enhances the growth of human keratinocytes in culture. Journal of Integrative Medicine, 2019, 17(2): 141-146.
[14] Alexandra R. Vaughn, Aunna Pourang, Ashley K. Clark, Waqas Burney, Raja K. Sivamani . Dietary supplementation with turmeric polyherbal formulation decreases facial redness: a randomized double-blind controlled pilot study. Journal of Integrative Medicine, 2019, 17(1): 20-23.
[15] Syed Nasir Abbas Bukhari, Fahad Hussain, Hnin Ei Thu, Zahid Hussain. Synergistic effects of combined therapy of curcumin and Fructus Ligustri Lucidi for treatment of osteoporosis: cellular and molecular evidence of enhanced bone formation. Journal of Integrative Medicine, 2019, 17(1): 38-45.
Viewed
Full text


Abstract

Cited
  Shared   
  Discussed   
[1] Wei-xiong Liang. Problems-solving strategies in clinical treatment guideline for traditional Chinese medicine and integrative medicine. Journal of Chinese Integrative Medicine, 2008, 6(1): 1-4
[2] Hao Li, Ming-jiang Yao, Wen-ming Zhao, Jie Guan, Lin-lin Cai, Ling Cui. A randomized, controlled, double-blind trial of Huannao Yicong capsule in senile patients with mild cognitive impairment. Journal of Chinese Integrative Medicine, 2008, 6(1): 25-31
[3] Jun Hu, Jian-ping Liu. Non-invasive physical treatments for chronic/recurrent headache. Journal of Chinese Integrative Medicine, 2008, 6(1): 31
[4] Wei Zhang, Xiang-feng Lu, Xiao-mei Zhang, Jian-jun Wu, Liang-duo Jiang. A rat model of pulmonary fibrosis induced by infusing bleomycin quickly through tracheal intubation. Journal of Chinese Integrative Medicine, 2008, 6(1): 60-67
[5] A-gao Zhou, Yong Zhang, Gang Kui, De-Yun Kong, Hai-liang Ge, Qiu-hua Ren, Jia-rong Dong, Sheng Hong, Xu-ming Mao, Yin Wang, Hui-zheng Zhang, Shu-jun Wang. Influence of traditional Chinese compound recipes with different efficacy on body weight, tumor weight and immune function in H22 cancer-bearing mice. Journal of Chinese Integrative Medicine, 2008, 6(1): 77-82
[6] Daniel Weber, Janelle M Wheat, Geoffrey M Currie. Inflammation and cancer: Tumor initiation, progression and metastasis,and Chinese botanical medicines. Journal of Chinese Integrative Medicine, 2010, 8(11): 1006-1013
[7] Xin-jun Wang, Ling-ling Wang . A mechanism of endogenous opioid peptides for rapid onset of acupuncture effect in treatment of depression. Journal of Chinese Integrative Medicine, 2010, 8(11): 1014-1017
[8] Yan-bo Zhu , Qi Wang, Cheng-yu Wu, Guo-ming Pang, Jian-xiong Zhao, Shi-lin Shen, Zhong-yuan Xia , Xue Yan . Logistic regression analysis on relationships between traditional Chinese medicine constitutional types and overweight or obesity. Journal of Chinese Integrative Medicine, 2010, 8(11): 1023-1035
[9] Hong Liu , Guo-liang Zhang, Li Shen , Zhen Zeng, Bao-luo Zhou, Cheng-hai Liu, Guang Nie . Application and evaluation of a pseudotyped virus assay for screening herbs for anti-H5Nl avian influenza virus. Journal of Chinese Integrative Medicine, 2010, 8(11): 1036-1040
[10] Ya-bing Zhou, Jian-er Yu, Jie Wu, Li Bai, Li-li Huo, Xin-guang Zhang, Li-qing Li . Effects of Chinese herbal medicine Bushen Gubiao Recipe on toll-like receptor 4 and CD4 +CD25 +foxp3 +regulatory T cells in mice with recurrent respiratory tract infections. Journal of Chinese Integrative Medicine, 2010, 8(11): 1053-1059
Journal of Integrative Medicine, ISSN: 2095-4964 CN 31-2083/R
Copyright © Journal of Integrative Medicine
Powered by Beijing Magtech Co. Ltd
沪公网安备31010602003416号      沪ICP备18017633号-3